Category
106 articles — page 5 of 9
May 14, 2026
Thyroid disease is the most common comorbidity in vitiligo — affecting roughly 20% of vitiligo patients. Understanding the connection, knowing which tests to request, and monitoring appropriately can meaningfully affect your health outcomes.
May 14, 2026
Vitiligo and albinism both involve reduced skin pigmentation but are completely different conditions — different genetics, different mechanisms, different distribution, and different treatment implications. Here is the clear distinction.
May 14, 2026
Leucoderma and vitiligo are often used interchangeably — especially in South Asian contexts — but they are not exactly the same thing. Here is the precise distinction, and why it matters for diagnosis and treatment.
May 14, 2026
Type 1 diabetes is the third most common comorbidity in vitiligo patients, sharing genetic susceptibility and immune mechanisms. Understanding the link, what to monitor, and how treatment choices interact across both conditions.
May 9, 2026
Focal vitiligo appears as one or a few small patches in a limited area. Most people want to know one thing: will it spread? A long-term study of 52 patients found 23% progressed to generalised vitiligo over 7 years. Here is what the data says about who is at risk and what to watch for.
May 9, 2026
Depigmented skin has zero melanin defence — it burns faster and tans unevenly. Here is exactly how to protect vitiligo patches, which sunscreen formulas to use, and how phototherapy patients should adjust their routine.
April 13, 2026
Gut health, stress reduction, diet, and supplements in vitiligo — a grounded look at what the research actually supports and where the evidence is genuinely thin.
April 13, 2026
Home narrowband UVB is one of the most effective options available to vitiligo patients — but getting the dose, timing, and safety protocol right matters. This guide covers how to use a home NbUVB device safely and effectively, including starting doses, progression, side effects to watch for, and how to protect sensitive areas.
April 13, 2026
For many patients, stopping vitiligo from spreading is a more urgent goal than repigmentation. Here is what the evidence shows works for stabilization — and what the triggers are that drive active spread.
April 13, 2026
Can you take a supplement to restore melanin in vitiligo? Here is what the research says about every supplement category — what has evidence, what is pure marketing, and what you should actually consider.
April 13, 2026
Ruxolitinib cream works well on the face but poorly on hands and feet. Here is why acral vitiligo responds differently and what combination strategies actually move the needle.
April 13, 2026
Ruxolitinib cream (Opzelura) combined with narrowband UVB is emerging as the most effective non-surgical approach for vitiligo repigmentation. Here is the evidence behind the combination, the practical protocol, and what you can realistically expect.
